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Abstract: In Escherichia coli, SigmaS (σS) is the master regulator of the general stress response. The
cellular levels of σS are controlled by transcription, translation and protein stability. The turnover of
σS, by the AAA+ protease (ClpXP), is tightly regulated by a dedicated adaptor protein, termed RssB
(Regulator of Sigma S protein B)—which is an atypical member of the response regulator (RR) family.
Currently however, the molecular mechanism of σS recognition and delivery by RssB is only poorly
understood. Here we describe the crystal structures of both RssB domains (RssBN and RssBC) and the
SAXS analysis of full-length RssB (both free and in complex with σS). Together with our biochemical
analysis we propose a model for the recognition and delivery of σS by this essential adaptor protein.
Similar to most bacterial RRs, the N-terminal domain of RssB (RssBN) comprises a typical mixed
(βα)5-fold. Although phosphorylation of RssBN (at Asp58) is essential for high affinity binding of
σS, much of the direct binding to σS occurs via the C-terminal effector domain of RssB (RssBC). In
contrast to most RRs the effector domain of RssB forms a β-sandwich fold composed of two sheets
surrounded by α-helical protrusions and as such, shares structural homology with serine/threonine
phosphatases that exhibit a PPM/PP2C fold. Our biochemical data demonstrate that this domain
plays a key role in both substrate interaction and docking to the zinc binding domain (ZBD) of ClpX.
We propose that RssB docking to the ZBD of ClpX overlaps with the docking site of another regulator
of RssB, the anti-adaptor IraD. Hence, we speculate that docking to ClpX may trigger release of its
substrate through activation of a “closed” state (as seen in the RssB-IraD complex), thereby coupling
adaptor docking (to ClpX) with substrate release. This competitive docking to RssB would prevent
futile interaction of ClpX with the IraD-RssB complex (which lacks a substrate). Finally, substrate
recognition by RssB appears to be regulated by a key residue (Arg117) within the α5 helix of the
N-terminal domain. Importantly, this residue is not directly involved in σS interaction, as σS binding
to the R117A mutant can be restored by phosphorylation. Likewise, R117A retains the ability to
interact with and activate ClpX for degradation of σS, both in the presence and absence of acetyl
phosphate. Therefore, we propose that this region of RssB (the α5 helix) plays a critical role in driving
interaction with σS at a distal site.
Keywords: RssB; SigmaS; AAA+ protease; ClpX; X-ray structure; adaptor protein
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1. Introduction
Bacteria are constantly exposed to a range of changing environmental conditions. Their ability to
adapt to each of these changes is central to their survival. Although some responses (e.g., the heat-shock
response) are highly tailored to specific environmental stresses, others (e.g., the general stress response)
offer broad cross-protection to the cell [1–3]. In Escherichia coli the general stress response is best
characterized by the transition from exponential growth to stationary growth and as such is regulated
by a specialized sigma factor, known as the starvation sigma factor, σs (also called σ38 or RpoS) which
is responsible for the induction of up to 100 gene products. Importantly, this response not only protects
cells from nutrient starvation but also from hyperosmotic stress, acid and alkaline stress, heat and
cold shock. Given σs plays such an important role in the cell, it’s not surprising that its activity and
levels are tightly controlled, not only at the transcriptional and translational levels, but also at the
post-translational level via ATP-dependent proteolysis [2,4,5].
In E. coli, cytosolic protein degradation is performed by five different AAA+ (ATPase associated
with a variety of cellular activities) proteases (ClpXP, ClpAP, HslUV, Lon, and FtsH). Typically, these
proteolytic machines recognize their substrates via a degradation sequence (degron), which is generally
located at the termini of the protein [6–9]. For the most part, each degron (and hence protein substrate)
is recognized by a single AAA+ protease, although on occasions a single degron may be recognized by
multiple AAA+ proteases [10]. In some cases, an additional component (termed an adaptor protein)
is recruited by the AAA+ protease for recognition of a specific substrate (or set of substrates). Some
adaptor proteins are essential for the recognition and delivery of their substrates (e.g., ClpS and the
turnover of N-degron substrates by ClpAP), while others simply alter the rate of substrate turnover
(e.g., SspB and the turnover of SsrA-tagged proteins by ClpXP) [11–15]. In the case of σs, a specialized
adaptor protein RssB, also referred to as SprE [16,17], is not only required for direct recognition of
the substrate but also required for its preparation and delivery to the AAA+ protease, ClpXP [18,19].
In addition to the adaptor protein RssB, the levels of σs are also controlled by an additional group
of proteins, termed anti-adaptors (e.g., IraD, inhibitor of RssB activity after DNA damage), all of
which inhibit the activity of RssB [20,21]. Each anti-adaptor is induced in response to a specific stress,
and currently three anti-adaptor proteins have been identified. Although the precise mechanism
of action of these anti-adaptors remains unclear, all are proposed to inhibit σs turnover via direct
interaction with RssB [22–24].
RssB is a response regulator (RR), and as such is composed of an N-terminal receiver (REC) domain
and a C-terminal output domain (also known as an effector domain). In contrast to most RRs (which
contain a DNA binding domain) RssB is linked to a protein binding domain, and as such represents one
of the small groups of RRs (~1% of all RRs). Nevertheless, like most RRs, RssB is phosphorylated on a
conserved Asp residue (Asp58) within the N-terminal REC domain. However, in contrast to most RRs
the physiological significance of RssB phosphorylation, and its effect on the output domain remains
unclear [18,25]. Despite this, the in vitro phosphorylation of RssB by acetyl phosphate (AcP) appears to
enhance both the recognition of σs (by RssB) and its turnover (by ClpXP). Currently however, despite
extensive research on this topic from several groups, little is known about the mechanism of substrate
recognition by RssB, its engagement with ClpX or its mechanism of substrate delivery to ClpX(P). For
example, which region(s) of RssB are responsible for substrate interaction? How does phosphorylation
of the N-terminal domain of RssB fine-tune substrate interaction? What are the molecular determinants
of RssB docking to ClpX? Is ClpX activated by this docking and how does substrate handover occur?
Previously we proposed (by virtue of a conserved C-terminal motif termed the ClpX binding region
(XBR) found in both RssB and SspB) that RssB delivered its substrate via docking of the adaptor to the
N-terminal zinc binding domain (ZBD) of ClpX [12].
Here we have performed a wide range of structural (X-ray crystallography and small angle X-ray
scattering (SAXS)) and biochemical (pull-down and degradation assays, immunoprecipitation, peptide
library screen, and chemical crosslinking) experiments to develop a model for the RssB-mediated
delivery of σs to the ClpXP. Our data demonstrate that the effector domain of RssB is necessary for
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interaction with both σs and ClpX. However, this domain alone is insufficient for substrate delivery to
ClpX, demonstrating that the N-terminal domain of RssB also plays a significant role in this process.
Consistently, our in vitro data show that phosphorylation of RssBN (at Asp58) modulates σs binding
and turnover. In addition, based on analysis of the RssB mutant (R117A), we have identified Arg117 as
a key residue that regulates σs interaction. Importantly, this residue is not directly involved in substrate
recognition, as σs binding to R117A is almost completely restored in the presence of AcP. Therefore,
we propose that Arg117 is a key “switch” residue, required to stabilize a substrate “engagement”
conformation of RssB, which is likely related to the phosphorylation-dependent conformation of
RssB. Significantly, Arg117 is located on the mobile α5 helix of RssBN, which is directly linked to the
C-terminal domain that makes direct contact to σs. Remarkably, despite significantly reduced ability
to recognize σs, the R117A mutant was able to facilitate σs turnover by ClpXP. Based on these data,
we speculate that docking (of RssB) to the N-terminal ZBD of ClpX, activates ClpX for σs recognition.
From our peptide library analysis, we propose that both the ZBD of ClpX and the anti-adaptor IraD
dock to a common or partially overlapping site within RssB and speculate that the interaction of the
ZBD with RssB may represent an elegant method to facilitate the timely release of σs into the hexameric
pore of ClpX. Hence, we propose that RssB docking to σs is not only essential for activation of the
substrate, but also required for docking to the ZBD of ClpX, thereby co-ordinating release of σs and the
activation of ClpX for substrate recognition and translocation into ClpP.
2. Materials and Methods
2.1. Cloning
Constructs encoding RssB mutants (D58E, D58K, K108A, K108R, K108D, RE/AA, and R117A)
were generated by site-directed mutagenesis [26] using either pHUE/RssB or pET32a/RssB as template
DNA. Refer to supplementary material for primer sequences (Table S1) and the final plasmid constructs
generated (Table S2). All clones were verified by nucleotide sequencing.
2.2. Protein Purification and Size Exclusion Chromatography
His6-tagged ClpX and ClpP were overexpressed in E. coli and purified as described previously [12].
Untagged σS, RssB (residues 1–337), RssBC (residues 131–337) and RssBN (residues 1–128) (wild
type and specific point mutants) were generated using the Ub-fusion system [27] and purified
essentially as described previously [24], using a combination of IMAC (immobilized metal ion affinity
chromatography) and preparative grade size exclusion chromatography (SEC) using a HiLoad 16/600
Superdex 200 to separate monomeric and dimeric RssB. All columns were pre-equilibrated in chilled
GF buffer (20 mM Tris-HCl pH 7.5, 10 mM MgCl2, 0.1 mM EDTA, 1 mM DTT, 140 mM NaCl, 5% (v/v)
glycerol, 0.005% (v/v) Triton X-100).
2.3. In Vitro Degradation Assays
The in vitro σS degradation assays were performed essentially as described [19] with minor
modifications. Briefly, ClpX (1 µM), ClpP (1 µM), monomeric RssB (80 nM) and 20 mM of the phospho
donor, acetyl phosphate (AcP) were pre-incubated in degradation buffer (20 mM Tris-HCl, 140 mM
NaCl, 10 mM MgCl2, 0.1 mM EDTA, 5% (v/v) glycerol, 0.005% (v/v) Triton X-100, 1 mM DTT, pH 7.5) at
30 ◦C, with 1 µM σS [28]. All reactions were initiated with the addition of 2 mM ATP and samples
collected at the specified time-points. Samples were separated using SDS-PAGE and visualized using
Coomassie Brilliant Blue (CBB) staining. Quantitation of protein bands was performed using either
GelAnalyzer or GelEval.
2.4. Glutaraldehyde Cross-Linking
Studies probing transient interactions between σs, the ClpX ZBD, RssB and the various RssB
derivatives were carried out using 35 µg of each respective protein in the presence of 0.005% (v/v)
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glutaraldehyde (GA) and 1x cross-linking buffer (20 mM Hepes-KOH pH 7.5, 140 mM NaCl, 10 mM
MgCl2, 0.1 mM EDTA, 5% (v/v) glycerol, 0.005% (v/v) Triton X-100, 1 mM DTT). Proteins were
pre-incubated in the absence of GA for 2 min. Upon initiating GA cross-linking, 50 µL samples were
collected at specified time points and diluted into 0.3 M Tris-HCl pH 8.8. Samples were prepared
in Laemmli buffer (1×) and separated by SDS-PAGE. Cross-linking products were visualized by
immunodecoration with the appropriate antisera.
2.5. Peptide Library
To identify RssB peptides interacting with the E. coli ClpX ZBD (ecClpXZBD), a commercially
derived RssB peptide library (JPT Peptide Technologies) composed of 13-mer peptides (overlapping by
10 residues) immobilized to a cellulose membrane (see Table S3 for peptide sequences), was panned
with ecClpXZBD, essentially as described previously [29] with some modifications. Pure ecClpXZBD
(2.5 µM) was incubated with the RssB peptide library in MP2 buffer (15.7 mM Tris-HCl pH 7.6, 100 mM
KCl, 20 mM MgCl2, 5% (w/v) sucrose, 0.05% (v/v) Tween20) for 30 min. with gentle shaking at room
temperature (RT). Upon completion of the previous incubation, the peptide library was washed with
ice cold TBS (50 mM Tris-HCl pH 8.0, 137 mM NaCl, 2.7 mM KCl) for 30 s, and then positioned on 4
pieces of pre-soaked (cathode buffer: 25 mM Tris-HCl pH 9.2, 40 mM 6-aminohexanoic acid, 0.01%
(w/v) SDS) 3MM Whatman blotting paper. The sandwich was then layered with a methanol (100%)
and Anode 1 (A1) buffer (30 mM Tris and 20% (v/v) methanol) soaked PVDF membrane, 4 × 3 MM
Whatman blotting paper soaked in A1 buffer and 4 × 3 MM Whatman blotting paper soaked in Anode
2 (A2) buffer (300 mM Tris, 20% (v/v) methanol). Bound protein was then transferred (6×) to a PVDF
membrane at a current of 1 mA × area (cm2) of the peptide library for the following times 30, 30, 20,
20, 30, and 30 min. The PVDF membrane was replaced after each transfer, while the 3MM Whatman
blotting sheets were only replaced after every second transfer. Bound proteins were detected by
immunodecoration using anti-ClpX antisera (1:1000 dilution in 3% (w/v) skim milk powder/TBS + 0.05%
(v/v) Tween-20 (TBS-T)), washed in 1 × TBS-T before being incubated with the appropriate secondary
antibody conjugated with HRP, and visualized using either a ChemiGenius2 (Syngene, Cambridge,
U.K.) or GelDoc™ XR + (Bio-Rad, Hercules, U.S.A.) imagining system and images captured using
Genesnap (Syngene) or QuantityOne (Bio-Rad) respectively. Figures were generated by overlaying 6
membrane images with adjusted transparency (100%, 50%, 33%, 25%, 20%) to ensure that all images
had equal contribution to the overall result.
2.6. In Vitro ‘Pull-Down’ Experiments
To examine the interaction of RssB (full-length or individual domains) with purified ZBD or σs,
in vitro “pull-down” experiments were performed essentially as previously described [24,30]. Briefly,
Ni-NTA agarose beads (QIAGEN, Hilden, Germany) (bed volume (BV), 25 µL) were equilibrated with
10 BV of equilibration buffer (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole) followed
by 5 BV of Wash Buffer C (20 mM Hepes-KOH pH 7.5, 100 mM KOAc, 10 mM MgOAc, 10% (v/v)
glycerol, 10 mM imidazole, 0.5% (v/v) Triton X-100). Proteins (25 µg) were pre-incubated in ice cold
Wash Buffer C (30 min. on a rotating wheel), then applied to Ni-NTA agarose beads and incubated as
previously described [24]. Samples were separated by centrifugation (800 g, 1 min, 4 ◦C), the beads were
resuspended in 5 BV of Wash Buffer C and transferred to individual MoBiTec (Molecular Biologische
Technologie) columns. The Ni-NTA agarose beads were then washed with 10 BV of Wash Buffer D
(20 mM Hepes-KOH pH 7.5, 100 mM KOAc, 10 mM MgOAc, 10% (v/v) glycerol, 20 mM imidazole,
0.25% (v/v) Triton X-100) and residual buffer removed via centrifugation (800 g, 1 min, 4 ◦C). Bound
proteins were eluted via centrifugation (800 g, 1 min, 4 ◦C) using 1 BV of Elution Buffer (50 mM
Tris-HCl pH 8.0, 300 mM NaCl, 250 mM imidazole). Samples were separated via SDS-PAGE and
proteins visualized by staining with Coomassie Brilliant Blue or transferred to a PVDF membranes for
visualization by immunodecoration with the appropriate anti-sera. Quantitation of protein bands was
performed using GelAnalyzer or GelEval.
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2.7. Co-Immunoprecipitation (Co-IP)
For co-IP experiments, specific IgGs were conjugated to Protein A Sepharose (PAS) Fast-Flow
beads (GE Healthcare), the beads were prepared as described [31]. Anti-serum (diluted 2-fold with
0.2 M KPi pH 7.5) was added to pre-equilibrated (in 0.1 M KPi pH 7.5) PAS beads and incubated (on
a rotating wheel) for 60 min at 4 ◦C. Unbound antibodies were removed from the bead suspension
by centrifugation (800 g, 3 min, 4 ◦C) before the beads were rinsed with 10 BV of 0.1 M Na-borate
pH 9.0. The beads were then incubated (30 min, 4 ◦C with gentle rotation on spinning wheel) with
10 BV of fresh 0.1 M Na-borate pH 9.0 containing 14 mM Dimethyl-Pimilimidate dihydrochloride
(DMP, Sigma), then the cross-linking process was repeated with the addition of fresh 14 mM DMP.
Conjugated IgG-PAS beads were then recovered via centrifugation (800 g, 5 min), rinsed with 10 BV of
1 M Tris-HCl pH 7.5 and incubated in 10 BV of 1 M Tris-HCl pH 7.5 for 2 h at 4 ◦C (gentle rotation on
spinning wheel). Finally, conjugated IgG-PAS beads were rinsed with 10 BV of 10 mM Tris-HCl pH 7.5
and stored on ice pending co-IP experiments.
Co-IP experiments were performed using purified recombinant proteins (0.14 nmol) and 20 µL
(settled BV) of cross-linked PAS beads (see above) essentially as described [32]. In brief, proteins
were pre-incubated in 1x co-IP buffer (20 mM Tris-HCl pH 7.5, 10 mM MgCl2, 140 mM KCl, 0.1 mM
EDTA, 5% (v/v) glycerol, 0.005% (v/v) Triton X-100, 1 mM DTT) and 10 mM AcP (Sigma-Aldrich) at 4 ◦C
for 30 min (gentle rotation on spinning wheel). Pre-incubated protein samples were then added to
cross-linked PAS beads and incubated for 60 min at 4 ◦C (gentle rotation on spinning wheel). Unbound
proteins were removed via centrifugation (800 g, 2 min, 4 ◦C), beads washed 5x with 5 BV of 1x co-IP
buffer and bound proteins recovered by centrifugation (16,060 g for 5 min) with 1 BV of 50 mM glycine
pH 2.5. Eluted fractions were neutralized in 250 mM Tris-HCl pH 8.0 and analyzed by SDS-PAGE.
2.8. Crystallization of RssBN and RssBC and Diffraction Data Collection
Initial sitting-drop crystallization trials of both domains were performed with the Honeybee 961
robot (Genomic solutions) using 13 commercial high throughput screens on 3:1 Corning 3550, 96-well
plates. Drops mixed from 0.4 µL of protein solution and 0.4 µL of reservoir solution were equilibrated
against 75 µL of precipitant solution at 20 ◦C. Crystals of different shape appeared under a variety of
conditions that were further reproduced under hanging-drop conditions. Crystals of RssBN suitable
for the X-ray data collection were obtained with a solution containing 20% (w/v) PEG 20,000 and 0.1 M
HEPES buffer, pH 7.5. Crystals of RssBC suitable for X-ray data collection were obtained with a mixture
containing 10% (w/v) PEG 8000, 0.2 M Li2SO4 and 0.05 M MES buffer, pH 6.5.
2.9. Structure Determination and Refinement
The structure of RssBN was solved by molecular replacement using the coordinates of 2PL1 as
starting model. The structure of RssBC was solved by multiple anomalous diffraction methods using
protein crystals soaked with Pt-salts. Protein crystals were flash-frozen in the presence of 20% (v/v)
glycerol. All x-ray crystallographic data were collected at beamline PX10 at the Swiss Light Source (SLS,
Villigen, Switzerland). The crystals were kept at 100 K during data collection, and a 360◦ dataset was
collected. Data were processed with the XDS/XSCALE [33] program package, and the structure was
solved using the SHARP/autoSHARP program package [34,35]. Initial model building was performed
in Arp/Warp and Buccaneer [36,37]. Subsequent improvement of models was achieved using the
PHENIX program package in combination with Coot for the construction of the models [38,39]. The
structure was analyzed using PROCHECK [40], and the figures were prepared using the PyMOL
program package.
2.10. Small Angle X-ray Scattering (SAXS) of RssB, σS and the RssB/σS Complex
SAXS experiments were performed on the SAXS/WAXS beamline at the Australian Synchrotron.
Preliminary experiments, performed with Trx-RssB as a static sample, indicated the presence of high
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MW aggregates, which interfered with the analysis. To overcome this problem, SEC in-line with the
synchrotron SAXS was used to fractionate samples and obtain scattering from the isolated species,
rather than mixtures. These SAXS data were collected using an established in-line gel filtration
chromatography protocol [41]. Sample injections of Trx-RssB (20 nmol), σS (35 nmol) and complexed
RssB- σS (at a 1:1 molar ratio, 12.5–15 nmol) in the presence of AcP (10 mM) were loaded onto a
Superdex 200 16/600 preparative column (GE Healthcare), pre-equilibrated in RssB gel-filtration buffer
(20 mM Tris-HCl pH 7.5, 10 mM MgCl2, 0.1 mM EDTA, 1 mM DTT, 140 mM NaCl, 5% (v/v) glycerol,
0.005% (v/v) Triton X-100), at a flow rate of 0.5 mL/min. For each run, 600 detector images were
collected as 2 s exposures every 2.1 s. The images were analyzed as averages of blocks of five sequential
exposures using the SAXS15ID software (Australian Synchrotron). Each image series was converted to
120 individual I(q) vs. q profiles, where I(q) is scattered X-ray intensity as a function of the momentum
transfer vector q = (4πsinθ)/λ, where the scattering angle is 2θ and the X-ray wavelength is λ (1.0332 Å).
The q range over which intensities were collected was 0.016-0.524 Å−1. SAXS data were analyzed
using the ATSAS suite of programs (version 2.4) [42]. Masses of the individual proteins and protein
complexes were estimated by Porod analysis using AUTOPOROD, while the radius of gyration (Rg)
was estimated by Guiner analysis using AUTORG. Pair distance vector distribution functions P(r) were
calculated using AUTOGNOM, which also yielded the maximum dimension (Dmax) of the scattering
particle and the forward scattering intensity, I(0). Final data sets were generated by averaging data
corresponding to the respective peaks where Rg, Dmax and the MW were consistent. Using the P(r)
curves as input, 10 DAMMIF models were generated for each species, which were then averaged
and filtered using DAMAVER [43]. Rigid body refinement of thioredoxin (Trx), RssBN, RssBC, and σS
with inclusion of linkers was attempted using BUNCH [44]. Nonetheless, due largely to the length of
the interdomain linkers, inconsistent domain arrangement solutions emerged. Therefore, both the N-
and C-domains of RssB were manually fitted into the shape envelope to provide a qualitative model
consistent with Trx at the N-terminus of the RssBN to determine the possible position of σS in the
Trx-RssB- σS complex.
3. Results
3.1. The RssB/σs Complex Docks to the ZBD of ClpX
Initially, to validate the idea that RssB and SspB use a common docking platform on ClpX for
delivery of its substrates to ClpXP, we performed a series of adaptor competition experiments in
which we monitored the RssB-mediated turnover of σs, in the absence or presence of SspB (Figure 1).
Consistent with our initial hypothesis, the RssB-mediated turnover of σs was inhibited by the addition
of SspB (Figure 1a, filled symbols). Indeed, in the presence of 15 µM SspB (the highest concentration that
we tested, Figure 1a, filled circles) the half-life (t1/2) of σs was increased by ~9-fold (i.e., from ~2.5 min
in the absence of SspB, to ~23 min). To ensure that the SspB-mediated inhibition of σs turnover was not
simply due to steric hinderance of the pore of ClpX (by SspB) we also monitored the RssB-mediated
turnover of σs in the presence of the XBR peptide from SspB (SspBXBR) (Figure 1b). Consistent with
docking of RssB/σs to the XBR docking site on the ZBD of ClpX, increasing concentrations of the
SspBXBR inhibited the turnover of σs (Figure 1b). Collectively these data suggest that interaction with
the adaptor docking platform on ClpX (i.e., the ZBD) is essential for the RssB-mediated delivery of
σs. However, during the early stages of this study the structure of RssB from Pseudomonas aeruginosa
was reported (PDB: 3EQ2) and it became apparent that the XBR motif of PaRssB was integral to the
protein fold and hence unlikely to be available for interaction with ClpX. Therefore, we modified our
hypothesis regarding the mechanism of σs delivery to ClpX, although based on the above results, we
maintained a focus on the role the ZBD in this process. Initially, we monitored the ClpP-dependent
turnover of σs in the presence of either wild type ClpX (Figure 1c, top panel) or a ClpX mutant
(∆ZBDClpX) which lacked the ZBD (Figure 1c, lower panel). As expected, σs was rapidly degraded
(t1/2 ~2.5 min) by wild type ClpXP in the presence of RssB (Figure 1c, top panel), while deletion of
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the ZBD of ClpX (∆ZBDClpX) completely inhibited the RssB-mediated turnover of σs (Figure 1c, lower
panel). Importantly, deletion of this domain does not affect the turnover of adaptor-independent
substrates such as SsrA-tagged proteins [12,13] demonstrating that ∆ZBDClpX retains full unfoldase and
ClpP-docking activities. Collectively, these data demonstrate that the ZBD of ClpX is essential for the
turnover of σs, likely as a docking platform for RssB. Of note, following consumption of σs, full-length
ClpX was cleaved into a smaller fragment (Figure 1c, lanes 5 and 6, upper panel). Interestingly,
and consistent with the findings of Houry and colleagues [45], this “clipping” appears to involve the
N-terminal region of ClpX as no such “clipping” was observed for ∆ZBDClpX (Figure 1c, lanes 5 and 6,
lower panel). Next, we asked the question, can the ZBD alone inhibit the RssB-mediated degradation
of σs, and if so, which component does it interact with? To address these questions, we performed
a series of competition assays, in which the RssB-mediated turnover of σs by wild type ClpXP was
monitored in the presence of increasing concentrations of the ZBD of ClpX (Figure 1d). Consistent with
Figure 1a, and docking of RssB to the ZBD of ClpX, the turnover of σs was inhibited upon addition of
increasing concentrations of ZBD (Figure 1d, filled symbols). These data clearly demonstrate that the
ZBD of ClpX is sufficient for interaction with RssB (and/or σs), however, it still remained unclear which
component(s) was directly involved in the interaction, or indeed how these protein(s) were recognized
by the ZBD.
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3.2. The C-Terminal Domain of RssB (RssBC) Docks Directly to the ZBD
Given the interaction between ClpX and RssB (or σs) is either transient and/or low affinity [19],
we decided to examine a possible interaction between the ZBD and RssB using chemical cross-linking.
Specifically, we incubated the ZBD with or without RssB, in the presence of GA. Initially as a control,
we examined the crosslinking of the His6-tagged ZBD alone (Figure 2a, lanes 1–6). As expected [15],
rapid dimerization of the ZBD was observed in the presence of GA (Figure 2a, lanes 1–6). These
data validate the experimental set-up of our system. Next, we monitored the formation of a complex
between His6-tagged ZBD (using anti-His antisera) and RssB (Figure 2a, lanes 7–12). Consistent with
a specific interaction between ClpX and RssB a crosslinked product was observed when the ZBD
was incubated together with RssB (Figure 2a, lanes 7–12). Significantly, this crosslink was absent
from control experiments, i.e., ZBD alone (Figure 2a, lanes 1–6) and more importantly the MW of
the crosslinked band (~45–50 kDa) was equivalent to complex containing a single copy of RssB (~38
kDa) together with a dimer of the ZBD (~12 kDa). To verify the presence of RssB within this crosslink,
the same reaction was probed with anti-RssB antisera (Figure 2b, lanes 7–12). Taken together, these
data suggest that (in the absence of σs) RssB can still interact with the ZBD of ClpX.
Next, in order to further dissect the interaction between the ZBD and RssB, we again performed
chemical crosslinking of the ZBD, however in this case we monitored crosslinking in the presence of
either RssBC or RssBN. Consistent with Figure 2a, rapid dimerization of the ZBD was observed in
the absence of RssB (Figure 2d). Interestingly, dimerization of the ZBD appears to be enhanced in
the presence of RssB (either full length or C-domain) (Figure 2a,d, respectively, lanes 10–12). More
importantly, addition of RssBC also resulted in the appearance of two additional crosslinked bands
(Figure 2c, ~30 and 40 kDa), which appear to contain both RssBC (Figure 2c) and the ZBD (Figure 2d).
Based on the apparent MW of the crosslinked complexes, we speculated that the smaller complex
(~ 30 kDa) represents a heterodimeric complex of RssBC crosslinked to a single ZBD (within the
RssBC- ZBD2), while the higher MW complex (~40 kDa) represents RssBC crosslinked to the ZBD
dimer (RssBC-ZBD2). Significantly, no cross-linking was observed for ZBD, in the presence of RssBN
(Figure 2c, lanes 3–8). Finally, in order to identify a potential ZBD docking site on RssB we examined
the binding of the ZBD to 13-mers from RssB using cellulose bound peptide library. Analysis of these
binding data identified a total of 8 “strong” binding peptides, found in three regions of RssB (Figure 2e),
one was located within the N-terminal domain (peptides 20–23) and two within the C-terminal domain
(peptides 81–82 and 90–91), which may represent docking sites for ZBD. Intriguingly, the putative
RssBXBR motif (peptide 109) was not recognized by the ZBD. Consistent with this finding, the RssBXBR
peptide (in contrast to the SspBXBR peptide, see Figure 1b) was unable to inhibit the ClpXP-mediated
turnover of σs (data not shown). Notably, alignment of the “strong” binding peptides revealed a
putative consensus binding motif for the ZBD (LKxh, where h = small hydrophobic and x = any amino
acid, see Figure 2f), which is highly similar to the XBR motif of SspB [12,46]. Therefore, based on these
data, we propose that RssB docks to the ZBD of ClpX (in a competitive manner to SspB), not through
the putative C-terminal XBR motif of RssB, but rather via an alternative XBR-like site, possibly defined
by peptides 81–82 or 90–91 (discussed later).
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Figure 2. Th ZBD of ClpX interacts with C-ter l domain of RssB. (a,b) The interaction of the ZBD
of ClpX with itself (lanes 1–6) or RssB (lanes 7–12) was examined by chemical crosslinki g si g 0.005%
(v/v) glutaraldehyde (GA). Following crosslinking, proteins were separated by SDS-PAGE, transferred
to PVDF membrane and probed with (a) anti-His antisera (for ZBD) or (b) anti-RssB (for RssB). In the
absence of any additional proteins, the ZBD of ClpX assembled into dimers (lanes 1–6). Following
the addition of RssB to ZBD (in the presence of GA) a specific crosslinked protein band (ZBD-RssB) of
~45 kDa was observed by immu decoration using (a) anti-His antisera and (b) anti-RssB ntisera.
# represents a non-specific crosslink f 2 ZBD dimers. (c) Th ZBD of Cl X forms a specific crosslink
with RssBC. Following crosslinking, proteins were separated by SDS-PAGE, transferred to PVDF
membrane and probed with anti-RssB antisera. In the absence of the ZBD, RssBN (lane 1) and RssBC
(lane 2) form dimers (indicated by *). In the presence of the ZBD of ClpX, a specific crosslink to RssBC
(lanes 9–14) and not to RssBN (lanes 3–8) was observed. (d) The ZBD of ClpX forms a specific crosslink
with RssBC. To confirm the presence of ZBD, reactions were probed with anti-His antisera. In the
absence of RssBC, the ZBD formed dimers (lanes 1–6). Following addition of RssBC an additional
crosslinked protein band (ZBD2-RssBC) was observed (lanes 9–12). (e) The ZBD interacts with 13-mer
peptides in RssB (numbering refers to peptide spots, sequences of “strong” binding peptides are
indicated). (f) Weblogo representation of the consensus motif for “strong” binding peptides to the ZBD
of ClpX.
3.3. Structure of the C-Terminal Phosphatase Domain of RssB
To gain structural insight into how RssB might interact with its various different co-factors (ClpX,
anti-adaptors or substrate) we attempted to solve the structure of RssB (full-length and individual
domains) either alone or in complex with several different partner proteins. Although we were
unsuccessful in crystallizing full-length RssB in complex with a partner protein, we did solve the
structures of both RssB domains. The structure of the RssBC was solved at 2.1 Å by multiple
isomorphous replacement (see Table S4). The RssBC domain structure is a mixed α/β-fold with five
α-helices and 11 β-strands and can be further divided into a mediator/connector domain (residues
131–163) connecting RssBN with RssBC and the actual C-terminal protein phosphatase (PP2C) domain
(residues 164–337). The N-terminal part or connector domain of RssBC comprises three small α-helices
(α6–α8) which are arranged with approximate angles of 90 degrees to each other (see Figure 3a). These
helices are connected to the core domain by salt bridges, hydrogen bonds and hydrophobic interactions,
but the conformation of the very first α6-helix is likely misaligned due to the absence of the structuring
RssBN domain. The α8-helix connects the mediating α-helical elements with the C-proximal and
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structurally conserved phosphatase domain, which consists of 11 β-strands and two α-helices. The
core structure of this domain is formed by a β–sandwich comprising two closely interacting β-sheets.
One-half of this sandwich domain is formed by the anti-parallel β-sheet of five β-strands in the
order β8-β9-β10-β11-β14 (Figure 3a). The two long helices (α9 and α10) connect the β9 and β10
strands and attach to this side of the beta sandwich domain. The second anti-parallel β-sheet of the
sandwich domain is formed by six β-strands in the following sequence: β6-β7-β16-β15-β12-β13. The
two β-sheets are stabilized through a hydrophobic core structure formed by conserved aromatic and
aliphatic residues.
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Figure 3. The structure of the C-terminal domain of RssB (RssBC) and superposition with close structural
homologs. (a) The structure of the C-terminal domain of RssB is shown in cartoon representation
from two perspectives related by a rotation of 90 degrees around the Y-axis. The structure is a mixed
α/β-structure formed by α-helices α6–α10 and β-sheets β6–β16. The C-terminal XBR-motif is shown
(boxed). (b) Surface representation of the C-terminal domain with the electrostatic potentials marked.
The left panel shows the same orientation used in (a), the right orientation was rotated by 90 degrees
around the x-axis. The putative active site is marked. (c) Structure comparison of RssBC shown in the
same orientation as in (a) with the C-terminal domain of RssB from P. aeruginosa displayed in dark
blue. (d) Superposition of RssBC shown in orange (same orientation as is (a)) with the serine/threonine
phosphatase structure of S. agalacticae shown in green (PDB-entry 2PK0). Magnesium atoms known to
be important for function of the phosphatase are marked in ball representation and active site residues
are shown in stick representation.
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Next we searched for structural homologs of this domain using the DALI server (http://ekhidna2.
biocenter.helsinki.fi/dali/). From this analysis we found the E. coli RssB-IraD complex to be the most
similar structure, with an r.m.s.d. of 2 Å (for 205 aligned residues, PDB-entry: 6OD1). The second
closest structure with an r.m.s.d. of 3 Å is the RssB protein from P. aeruginosa which was crystallized in
different crystal forms either as the full-length protein or an individual domain (PDB-entries: 3F79,
3F7A, 3EQ2 and 3ES2, respectively). In superposition, this structure exhibits a surprisingly weak
sequence identity of 16% and shows two additional helices connecting the last two β-strands (see
Figure 3c). The conserved residues (between EcRssB and PaRssB) are mostly located in the hydrophobic
interface but also include two positively charged surface exposed patches, one of which (Figure 3b,
right panel) is centered around the putative phosphatase site that corresponds to the peptides 90 and
91 from the peptide library and hence may play a role in docking to the ZBD of ClpX.
RssBC also shares structural similarity with RsbX, another protein phosphatase from Bacillus
subtilis. Although BsRsbX shared an r.m.s.d. of 2.8 Å with EcRssBC (for 155 aligned residues; PDB-entry:
3W41), it only shares 9% sequence identity with EcRssBC in structural superposition [47]. Interestingly,
the active site of BsRsbX contains a metal ion which is coordinated by three Asp residues, however only
one of these Asp residues (Asp204) is conserved in EcRssB. The RssBC also shows structural homology
to a variety of other phosphatase domains in the PDB with r.m.s.d. of ~3 Å and low structural sequence
identity of ~10%. The superposition of RssBC onto the serine/threonine phosphatase from Streptococcus
agalactiae as representative of this class of phosphatases is shown in Figure 3d.
3.4. The N-Terminal Domain of RssB Adopts the Fold of a Two Component System Regulator
The structure of RssBN was solved to 2.05 Å by molecular replacement using the PhoP response
regulator structure (PDB-entry: 2PL1) as a search model. Overall, the structure consists of five repetitive
(αβ)-elements which form a parallel β-sheet (β2–β1–β3–β4–β5–) sandwiched by two helices (α1 and
α5) on one side and three helices (α2–α4) on the opposite side (Figure 4a). A structural search of the
PDB identified unpublished structures of E. coli RssBN (PDB-entry: 3EOD) and P. aeruginosa RssB
(PDB-entry: 3F7A) to be the most similar models with an r.m.s.d. of 0.4 Å and 1.3 Å, respectively.
The next most similar target was the E. coli RssB-IraD complex (PDB-entry: 6OD1). Superposition
of RssBN onto the RssB/IraD structure revealed an r.m.s.d. of 1.4 Å. While the core structure of this
domain is well preserved (with the exception of small deviations around Asp58), there were clear
changes in the conformation of the α5 helix across the structures. Interestingly, in contrast to most
RRs this helix is somewhat unique as it is predicted to be the structural motif that connects the N- and
C-terminal domains of RssB via an extended coiled coil structure (PDB-entry: 3F7A). From analysis of
the B-factors of RssBN (which resemble molecular flexibility) it became obvious that the last helix (α5),
in particular, shows higher mobility (see Figure S1). This is supported by the observation of limited
hydrophobic contacts between this helix and the core domain structure. The reason for these high
B-factors may either be functional or may have occurred due to the crystal packing where the two
monomers are packed in a non-biological orientation. Importantly, mutations in this region have a
dramatic effect on the regulation of substrate binding (discussed below).
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Collectively, these data suggest that weak dimerization of EcRssB likely occurs through the 4-5-5 
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Figure 4. The structure of the N-terminal domain of RssB (RssBN) and putative dimer. (a) Structure of
the N-terminal domain shown in cartoon representation and color coded from the N- (NT; Met1; in blue)
to the C-terminus (CT; Ser127; in red) using rainbow colors. The structure is shown from three different
angles which are related by rotation of 90 degrees around the y-axis and second rotation of 90 degrees
around x-axis. The five-stranded β-sheet (β1–β5) is surrounded by α-helices (α1–α5). (b) Structure
of RssBN in the same orientation as in (a) as surface representation with conserved residues colored
in blue and named according to the sequence. Hydrophobic residues are marked in orange, glycine
residues are marked in yellow, hydrophilic residues are marked in magenta and charged residues
are marked in red. The conserved phosphorylation site on Asp58 is marked with a yellow rectangle.
There are two conserved patches visible on the surface. The conserved groove on the left represents a
putative dimerization interface, while the extended and conserved surface on the right is indicative for
interactions with the substrate protein σs after phosphorylation. This patch is particularly negatively
charged with a high density of acidic residues. (c) Comparison of the N-terminal domain structures of
RssB from E. coli (EC—in dark orange and dark blue) and P. aeruginosa (PA—in light orange and light
blue). Three different perspectives are shown. The structures are virtually identical for the β–sheet and
adjacent α–helices but varies in loop structures (superimposed with a r.m.s.d. of 1.3 Å). In the lower
images the electrostatic surface of one of the subunits from the E. coli protein is illustrated.
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Similar to several REC domains, our structure of RssBN formed a dimer in the asymmetric unit.
However, in contrast to many RRs the RssBN dimer showed an anti-parallel orientation, which is
mainly stabilized by β-strand augmentation via the terminal β2-strands. This orientation is different
to the biologically active dimer of several RRs including PhoP from E. coli. It is also distinct from the
parallel arrangement observed in the structure of full-length P. aeruginosa RssB protein, where the
opposite face (formed by α4-β5-α5, here termed the 4-5-5 interface) contact one another. Therefore, to
examine if the conserved 4-5-5 interface of E. coli RssB was involved in dimerization, we modelled
the dimer of EcRssBN using the dimeric, full-length PaRssB structure (Figure 4c). Using this template,
the dimeric RssBN model only yielded a small interacting surface area. This small interface may
explain why the two domains interact only weakly in solution and may form alternative dimerization
sites. Nevertheless, consistent with a role for the 4-5-5 interface in EcRssB dimerization, mutation of
L106 was previously shown to stabilize dimer formation as determined by chemical cross-linking
experiments [24]. To examine the possibility that a region equivalent to the coiled-coil region of
PaRssB also contributes to the weak dimerization of EcRssB, we compared the primary sequence of
both proteins. Consistent with secondary structure predictions and the recent structure of RssB (in
complex with IraD [23]), EcRssB lacks most of the key coiled-coil residues found in PaRssB (Figure
S1b). Collectively, these data suggest that weak dimerization of EcRssB likely occurs through the 4-5-5
interface but does not involve formation of a coiled-coil domain.
Next we examined which residues on the surface of RssBN were conserved. From this analysis we
identified two conserved regions (see Figure 4b). As expected, the first conserved region was formed
by the loops L1, L3, and L5, which are located at the distal end of the molecule. This conserved patch
includes Asp58 (the site of phosphorylation) and is surrounded by additional charged residues (see
Figure 4b and c; Glu14, Asp15, and Glu16) which together coordinate a magnesium ion. The second
conserved region forms a groove (Figure 4b), which centers on the C-terminal part of the protein
(including the β5 strand). This groove includes Lys108, which forms salt bridges with Asp58 and Glu14
and is involved in transmitting the phosphorylation signal from the REC domain to the C-terminal
output domain (see later).
3.5. The C-Terminal Domain of RssB is Required for σs Docking
Next we asked the question, how does RssB interact with σs? To address this question, we
examined the interaction of σs with RssB (full length and individual domains) using a range of in vitro
techniques. Initially we monitored the interaction between RssB and σs by co-immunoprecipitation
(co-IP) using anti-σs antisera (Figure 5a). As expected, immunoprecipitation of wild type RssB was
observed in the presence of σs (Figure 5a, lane 2). Importantly, the level of RssB recovered (in the
presence of σs), was significantly higher than in the absence of σs. The small recovery of RssB (in
the absence of σs) is likely due to a weak non-specific interaction of RssB with the beads to which
the antisera was immobilized (Figure 5a, lane 1). Next we examined the ability of RssBN (Figure 5a,
lanes 3 and 4) or RssBC (Figure 5a, lanes 5 and 6) to interact with σs and determined the relative
importance of each domain by quantitating four independent co-IP experiments (Figure 5b). Similar
to wild type RssB, and consistent with an important role for the C-terminal domain in σs interaction,
RssBC was co-immunoprecipitated in the presence of σs. Importantly, the level of RssBC recovered
(in the presence of σs) was significantly greater than in the absence of σs (Figure 5b). In contrast to
RssBC, little-to-no RssBN was recovered by co-IP using anti-σs antisera, suggesting that the N-terminal
domain plays only a minor direct role in the interaction. Overall, these data clearly show that RssBC
plays a significant direct role in σs binding, however the apparent binding affinity of RssBC (with σs) is
substantially compromised given much less RssBC was recovered by co-IP (in comparison to wild type
RssB). Hence, other regions (or conformations) of RssB are likely required for direct interaction with σs.
Consistent with these data, phosphorylation of RssB (on the N-terminal domain) enhances σs binding
(see Figure 6).
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(to visualize Trx- - ssB). The input (5 ) is sho n in the upper panel and the eluted proteins (40 )
are sho n in the lo er panels. (b) Quantitation of in vitro σs co-IP experiments show the binding
of σs to Trx-H6-RssBN (white bar) and Trx-H6-RssBC (grey bar), relative to wild type Trx-H6-RssB
(black bar). Error bars represent S.E.M. of at least three independent experiments (n > 3). (c) In vitro σs
“pull-down” experiment illustrating the interaction of σs (lane 1) with wild type Trx-H6-RssB (lanes
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shown in the upper panel and the eluted proteins (50%) are shown in the lower panels. (d) Chemical
cros linking of σs (using 0.005% (v/v) GA) was monitored in the absence (lanes 1–6) or presence (lanes
7–12) of RssBC. Following crosslinking, proteins were separated by SDS-PAGE, transferred to PVDF
membrane and probed with anti-σs antisera. * represents non-specific σs crosslink products.
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To validate these findings, we performed a series of experiments in which the bait was reversed.
In this case, we immobilized Trx-H6-RssB (wild type, RssBN or RssBC) to Ni-NTA-beads and incubated
each column with untagged σs (Figure 5c). As expected, σs was recovered from the pulldown using
full length RssB (Figure 5c, lane 3). Importantly, reversing the bait reduced the level of non-specific
binding of RssB. Consistent with the co-IP experiments, a significant amount of σs was also recovered
from column bearing immobilized RssBC (Figure 5c, lane 7), while only a very small amount of σs was
recovered from the column bearing immobilized RssBN (Figure 5c, lane 5). Taken toge her, these data
validate a direct ole for the C-terminal effector doma n of RssB in σs recogn tion (Figure 2 ). Finally,
to confirm the identification of RssBC as th primary docking site fo σs, we performed a series of
non-specific cross-linking experiments u ing GA, in which σs was incubated in the bsence or presence
of RssBC. In order to identify σs specific crosslinks, we monitored the crossli ked protei s using a ti-σs
antisera (Figure 5d). Consistent ith the co-IP and affinity pull-down experiments, a specific cross-link
product (~50 kDa), accumulated in the presence of σs and RssBC (Figure 5d, lanes 8–12), which was
absent from the σs alone experiment (Figure 5d, lanes 1–6). Importantly, the MW of this crosslinked
product (~50 kDa) was equivalent to the theoretical MW of a heterodimeric complex of σs and RssBC.
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3.6. Mutations in RssBN Regulate Phosphorylation Dependent σs Binding
Based on the findings above, the effector domain (RssBC) is primarily responsible for direct
interaction with σs, however this domain alone, only appears to account for about one third of the total
binding activity/affinity ofσs (in comparison to wild type RssB). Furthermore, the receiver domain alone,
also contributes little to the direct binding of σs, yet phosphorylation of this domain appears to play a
significant role in the interaction. This suggests that substrate binding to RssBC is either significantly
enhanced (or stabilized) by phosphorylation of the N-terminal receiver domain or alternatively that
recognition of σs extends beyond docking to RssBC and likely includes a region of RssB, which is only
exposed in the full-length protein and can be enhanced by phosphorylation of the N-terminal domain
(such as the linker region between the two domains). However, a systematic in vitro analysis of the
effect of phosphorylation and events that contribute to phosphorylation dependent conformational
changes in RssB have yet to be examined in detail, as such the importance of RssB phosphorylation
remains controversial. Therefore, we compared the rate of σs turnover in vitro in the absence or
presence of AcP (Figure S2). Consistent with published findings, the addition of AcP enhanced the
RssB-mediated turnover of σs. The apparent Km for the turnover of σs by unphosphorylated RssB was
calculated to be ~150 nM, which decreased ~3-fold (Km ~58 nM) in the presence of phosphorylated
RssB (RssB~P). These data clearly demonstrate, that although phosphorylation of RssB is not essential
for the turnover of σs it does alter its affinity for the substrate. Next, we generated a series of mutations
within RssBN to dissect the mechanism of activation by phosphorylation. As expected, mutation of
Asp58 (the site of phosphorylation) abolished all phosphorylation-dependent activities of RssB. While
the phospho-mimic mutant D58E enabled a “strong” interaction with σs (~75% of RssB~P) this binding
was no longer activated by the addition of AcP (Figure 6a, red bars). In contrast, replacement of
Asp58 with Lys, not only resulted in a significant reduction to σs binding but also resulted in a loss of
activation by phosphorylation (Figure 6a, orange bars). Consistent with a loss of binding to σs by both
mutant proteins, there was a corresponding loss in the RssB-mediated degradation of the substrate
by ClpXP (Figure 6d). Taken together these data suggest that phosphorylation of Asp58 stabilizes a
“substrate-binding” conformation of RssB.
Next, to examine how the phosphorylation of Asp58 is signaled to the rest of the protein, we
mutated Lys108 (which forms a H-bond with Asp58) (Figure 6c). Consistent with mutation of Asp58,
replacement of Lys108 (with either arginine, aspartate or alanine) not only reduced σs interaction
significantly, but also abolished the phosphorylation dependent activity of RssB (Figure 6a, purple
bars, data not shown). These data suggest that Lys108 is, not only, critical for the formation of the
“activated” complex—that recognizes σs with high affinity, but it also plays a critical role in sensing
Asp58 phosphorylation. Finally, we speculated, that the signaling of Asp58 phosphorylation would be
transferred to the C-terminal via an extended helix composed of α5 (from RssBN) and α6 (from RssBC).
Serendipitously, in our search for XBR-like motifs in RssB, we had already generated a mutation
with the 116LREM119 motif located in the α5 helix. To examine the role of this region in σs turnover, we
replaced the charged residues (RE), central to this motif, with alanine (here termed RE/AA). Initially we
examined the ability of wild type or mutant RssB, to bind σs and deliver it to ClpXP for degradation,
in the presence and absence of AcP. Interestingly, although σs recognition by this mutant was completely
abolished in the absence of AcP, substrate interaction (and degradation) was partially restored in the
presence of AcP (Figure 6b and Figure S3). These data suggest that rather than playing a direct role
in σs binding, the RE motif appears to play an important role in stabilizing the “substrate-binding”
conformation of RssB. One interpretation of these data is that the RE motif guides RssB towards
the substrate “engaged” state, however activation to the “high affinity” conformation still requires
phosphorylation. Importantly, activation by phosphorylation can overcome this defect in σs binding.
Next, to further dissected this motif, we generated a single point mutant in which Arg117 was replaced
with Ala (RssBR117A) here termed R117A. Consistent with the RE/AA mutant, substrate recognition by
R117A was again absolutely dependent on phosphorylation (Figure 6a, blue bars). Taken together
these data suggest that Arg117 is a critical “switch” residue required for σs recognition, in the absence
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of phosphorylation. We speculate that this residue forms an important element in the formation of
an “engaged” conformation, possibly via a key interdomain interaction. Notably, the R117A mutant
retained the ability to “deliver” σs to ClpXP, both in the presence and absence of AcP (Figure 6e,
squares) despite no observable interaction with σs in the absence of AcP (as determined by pull-down,
see Figure 6a,b). These data suggest that (i) σs preparation only requires a transient interaction with
RssB and (ii) activation of ClpX (by RssB) is required for σs turnover, and (iii) R117A retains the ability
to interact with and activate ClpX for σs turnover.
Next, in order to better understand the interaction between σs and RssB we performed small-angle
X-ray scattering (SAXS). Given the apparent conformational flexibility of RssB, we used the R117A
mutant (in the presence of AcP) to limit different conformations of RssB. Preliminary SAXS experiments
of RssB alone indicated the presence of high MW scattering particles, consistent with aggregated
proteins. To remove these contaminating aggregated proteins, which interfered with the SAXS analysis,
samples were fractionated by SEC in-line with SAXS data collection. The SEC elution profile (Figure 7a),
of Trx-RssB and σs alone indicated that aggregated protein (Ve ~52 mL, Figure 7a) was well separated
from monomeric Trx-RssB and monomeric σs, both of which eluted with a volume of ~90 mL (Figure 7a,
red and blue lines respectively). As expected, the Trx-RssB/σs complex eluted earlier (Ve ~82 mL) than
either protein alone (Figure 7a, black line) and importantly was clearly separated from the aggregated
protein peak. The SAXS data obtained for Trx-RssB, σs and the Trx-RssB/σs complex (Figure 7b, red,
blue and black lines, respectively) were analyzed to reveal information about MW and shape (Table S5).
Based on an estimate of the volume of the scattering particle, termed Porod analysis, the MW of
Trx-RssBR117A was determined to be 49 kDa. This MW was similar to the theoretical mass of Trx-RssB,
(determined from its amino acid sequence; 52 kDa), and hence is consistent with Trx-RssB forming a
well-structured protein composed of globular domains. In contrast, the MW for σs (as determined by
analysis of the SAXS data) was 45 kDa, which is higher than the theoretical MW of σs (38 kDa). This
could indicate some self-association and/or a higher apparent volume due to significant conformational
averaging. Both Trx-RssB and σs had similar maximum dimensions (~105 Å) and very similar Rg
values (~31 Å), consistent with both proteins being elongated and composed of multiple domains. The
SAXS analysis of the Trx-RssB/σs complex indicated a MW of ~91 kDa (in comparison to the theoretical
MW of 92 kDa), which is also in good agreement with the sum of the SAXS-derived mass of each
component (45 + 49 = 94 kDa). It also suggests that the factors that caused a high apparent mass for σs
(self-association and/or conformational averaging) may persist in the complex. However, the Dmax of
the Trx-RssB/σs complex is only ~25 Å longer than either of the individual components, suggesting
these elongate components bind in a somewhat more globular arrangement.
Ab initio shape reconstruction of the SAXS data supports this with both isolated components
being relatively narrow and elongate (Figure 7c,d), while the complex is considerably wider at one
end (Figure 7e). An atomic resolution structure is not available for σs, however based on homology
to other E. coli sigma factors (free or in complex with RNA polymerase; PDB: 1SIG, 1L9U, 1KU2 and
3IYD), σs is expected to be highly flexible and likely to change its structure upon complex formation.
Model building using rigid body refinement of linked structural fragments against the SAXS data
was attempted, but in the absence of an experimental structure for σs and with long inter-domain
linkers, no consistent solutions emerged. Thus, the X-ray crystal structures of RssBN and RssBC (see
Table S4) together with the structure of Trx, were manually docked into the Trx-RssB envelope, using
the relatively small Trx domain as a reference point. Trx was used to orient the organisation of the
complex and positioned in the narrow protrusion at one end of the envelope (RssBN and RssBC were
too large to occupy this site), RssBN was placed proximal to Trx, and RssBC was positioned in the
remaining distal unoccupied electron density (Figure 7c). Assuming Trx-RssB maintains a similar
domain arrangement in the complex, comparison of the ab initio shape envelope of the Trx-RssB/σs
complex with free Trx-RssB was performed (Figure 7e). This suggests that σs may wrap around the
end of Trx-RssB, distal to Trx, making contact with both the N- and C-terminal domains of RssB.
While other orientations may be possible, this arrangement, where σs binding seems to be mediated
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predominately through the C-terminal domain of RssB, is consistent with in vitro pull-down and GA
cross-linking experiments.
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Finally, we examined the mechanism of delivery of σs (by RssB) to ClpX(P). Previously, it was
proposed that the N-terminal region of σs contains a ClpX-docking motif [9,48] and exposure of this
motif (by RssB) was required for delivery of σs to ClpX. To confirm this possibility, we generated a
deletion mutant of σs which lacked the first 50 residues of σs. Initially, we tested the ability of RssB to
deliver wild type or mutant σs to ClpX for degradation by ClpP (Figure 8a). Consistent with the findings
of Hengge and colleagues [48], deletion of the first 50 residues of σs abolished the RssB-mediated
turnover of σs (Figure 8a, compare lanes 1–5 with lanes 6–10). Next to ensure that removal of 50
residues from the N-terminus of σs did not compromise RssB interaction, we examined the ability of
∆NσS to compete with the RssB-mediated turnover of wild type σS. Importantly, the RssB-mediated
turnover of σS was inhibited in the presence of equimolar concentrations of ∆NσS (Figure 8a, blue
squares). This turnover was further inhibited in the presence of a 2-fold (Figure 8a, red triangles) and
5-fold (Figure 8a, green diamonds) excess of ∆NσS. Indeed, in the presence of a 5-fold excess of ∆NσS
the half-life of σS increased from ~2.5 min to ~ 20 min. In order to confirm that ∆NσS retained the
ability to interact with RssB we performed a series of pull-down experiments (Figure 8b). Consistent
with the substrate competition experiments, equal amount of wild type or ∆N σS were recovered from
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immobilized RssB (Figure 8b, compare lanes 4 and 7, respectively). Collectively, these data suggest that
RssB is required for the release of the N-terminal ClpX binding motif, which is recognized by ClpX.
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4. Discussion
The gen ral stress response is a crucial cros -prot i r sponse pathway. In E. coli the
pathway is controlled by a specialized sigma factor, σS. Given the importance of this pathway it is not
surprising that the levels of σS are highly regulated, not only at the transcriptional and translational
level but also post-translational level. Consistent with the stringent control of σS levels in the cell,
the turnover of σS is strictly regulated by many different cellular components, including ATP levels
and several different proteins (adaptors and anti-adaptors) [22,24,25]. A key regulator of the pathway,
that is central to the turnover of σS, is the adaptor protein RssB. This adaptor protein is a member
of the RR family and as such is composed of two domains, an N-terminal REC domain that can be
phosphorylated on a conserved Asp residue (Asp58) and a C-terminal effector domain. However,
in contrast to most RRs (in which the effector domain is involved in DNA binding) RssB is an atypical
member of the RR family as the effector domain is involved in protein binding. Indeed, the effector
domain of RssB exhibits a PPM/PP2C phosphatase fold, however it lacks the active site residues. For
these reasons, the mechanism of action of RssB has remained poorly understood [49]. Here we report
the functional characterization of RssB, using a range of biochemical (pull-downs, immunoprecipitation
and chemical crosslinking) and structural approaches. Our data help define the mechanism of action
of this intriguing adaptor protein, how it interacts with, prepares, and delivers its substrate (σS) to the
unfoldase (ClpX) for degradation by ClpP. Based on our data, together with published findings we
propose a model for the engagement of RssB with its substrate σS, its docking to ClpX and the delivery
of σS to the ClpXP protease.
Similar to other AAA+ adaptor proteins, RssB docks to its cognate unfoldase component (ClpX)
via a specific interaction with the N-terminal ZBD [12,13,15,50,51]. The C-terminal effector domain
of RssB is essential for this docking (Figure 2). However, in contrast to our previous model [12],
the interaction (between RssB and the ZBD) is mediated, not via the C-terminal sequence of RssB (as
it is critical to the fold of RssB) but rather by an alternative XBR-like region within the C-terminal
domain (Figure 1). Based on our peptide library analysis we propose that the ZBD of ClpX interacts
with the α10 helix of RssB (Figure 2). Interestingly, this region was also recently identified as part of
the IraD binding site in RssB [23]. Collectively, this suggests that both the ZBD of ClpX and IraD share
a common or overlapping docking site within RssB. Hence, we propose that docking of IraD to this
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site is likely, not only, to prevent σS binding to RssB, but also prevent the delivery of σS to ClpX(P).
Interestingly, in addition to its interaction with IraD and ClpX, the C-terminal domain of RssB appears
to bind to all components of the pathway, as it also makes direct contact to the anti-adaptors, IraM
and IraP, [22–24] as well as the substrate, σS (Figure 5). This suggests that the C-terminal domain of
RssB represents a “hub” for the competitive docking of most, if not all, factors involved in σS turnover
(Figure 9). This, competitive binding to a common or overlapping platform in RssB, is an efficient way
to ensure that σS turnover can be rapidly and reversibly controlled.
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Although the C-ter inal do ain of RssB serves as a co on site for docking of each of the
different co ponents involved in the turnover of the σS, the interaction of any of these co ponents
is odulated by the N-ter inal do ain. In some cases, the interaction (e.g., with σS) is enhanced
by phosphorylation. Although the physiological significance of RssB phosphorylation re ains
controversial, our in vitro data suggests that si ilar to other RRs [49], the phosphorylation of RssB
enhances its biological activity, as it increases both the binding and turnover of σS by ~3-fold. Based
on our utational analysis of conserved residues located ithin the -do ain, e propose that
phosphorylation of RssB (at Asp58) is sensed by the conserved residue (Lys108) located within the
4-5-5 interface. This interaction stabilizes the α5 helix of RssB in an “activated” conformation which
facilitates high affinity recognition of σs. Interestingly, consistent with an important biological role for
this region, our structural comparisons of RssB with several other RRs, including the recent structure of
the RssB-IraD complex (r.m.s.d. of 1.4 Å), demonstrated that this region is mobile as the α5 helix was
observed to adopt several different conformations (Figure S4). Similarly, this region displayed high
B-factors in our structure of the REC domain. Consistent with an important role for the α5 helix, we
also discovered that, in the absence of phosphorylation, a single residue (Arg117, located on the distal
end of α5 helix) was essential for substrate interaction (Figure 6). Importantly, although this residue is
essential for σS binding in the absence of phosphorylation, the interaction with substrate was restored
in the presence of AcP (Figure 6). These data clearly demonstrate that Arg117 is not directly involved in
substrate interaction, but rather promotes or stabilizes a conformation of RssB that supports substrate
interaction. Interestingly, movement of the α5 helix (in the RssB-IraD complex) places Arg117 at the
interface of both RssB domains and IraD, where it forms a H-bond with Gln247 of the C-domain [23].
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Therefore, we speculate that Arg117 represents a “switch” residue in RssB, that depending on the
position of the α5 helix, either stabilizes RssB in an “activated” state or an “inhibited” state.
Adaptor proteins are specific recognition factors that regulate the delivery of a particular substrate
(or class of substrates) to an individual AAA+ protease [11,13,14,52]. Overall, these proteins can be
classified into two groups, based on their mechanism of action. The first group are scaffold adaptors,
which tether the bound substrate to the AAA+ unfoldase. These proteins (e.g., the ClpX adaptor SspB,
involved in the turnover of SsrA-tagged substrates) generally enhance the rate of substrate turnover
for a substrate that is intrinsically recognized by its cognate AAA+ unfoldase. Typically, this type of
adaptor is composed of two well-defined regions—a substrate binding domain and a protease docking
region. The second group of adaptors are “activating” adaptors. In contrast to the “tethering” adaptors,
these proteins (e.g., ClpS, MecA, and RssB) are essential for the turnover of one or more substrates,
and as a result the mechanism of action is generally more complex. Some “activating” adaptors (such
as MecA and McsB) control AAA+ protease assembly and hence are generally required for most
proteolytic activities of that machine [53,54], while other “activating” adaptors are only required for the
delivery (and turnover) of a specific substrate (or substrate class). In the second group of “activating”
adaptors, the adaptor protein may be required either for substrate activation or substrate delivery or in
some cases both activities. One of the best characterized examples of an “activating” adaptor is the
N-recognin, ClpS, which is essential, not only, for N-degron recognition but also for the substrates’
subsequent delivery to ClpA [55–58]. In this case, the delivery process can be separated into several
important steps, from low affinity docking to the N-terminal domain of the AAA+ protein, activation
of the unfoldase and ending in active substrate release. Similar to ClpS, we propose that σS delivery by
RssB involves a number of discrete steps. In the first step, RssB interacts with its substrate σS. This
interaction is primarily mediated by direct contact to the C-terminal domain of RssB, however docking
to this domain can be modulated in the presence of the N-terminal domain, which can be enhanced
by phosphorylation. In the absence of phosphorylation, a specific residue, R117 (located on the α5
helix between the two domains) controls substrate “engagement”. We speculate that R117 plays a
key role in stabilizing different RssB conformations. Finally, after engagement with the substrate, it’s
been proposed that the N-terminal region of σS is “revealed” for delivery to ClpX. In addition to this
“preparation” step, we speculate that RssB is also require for activation of ClpX. This is based on the
identification of several RssB mutants that fail to bind σS but yet still facilitate σS turnover (Figure 6).
5. Conclusions
In contrast to several bacterial adaptor proteins, the mechanism of action of RssB has so far proved
elusive. Progress in this field has been largely hampered by the atypical domain structure of this RR,
the weak affinity of its individual components (for their binding partners) and until recently, by a lack
of structural information for any of the proteins involved in the turnover of σS. To overcome the weak
affinity of the various interactions, we have used chemical crosslinking to help define the molecular
steps involved in the recognition of σS by RssB and its delivery to ClpX. Importantly, we have been able
to validate each of these interactions using a number of different approaches. In addition to describing
the broad details of these interactions, we have also identified several important residues within the
N-terminal REC domain of RssB that are required for the phosphorylation dependent recognition of its
substrate. We have also identified a single residue (R117), that is essential for σS recognition (in the
absence of phosphorylation), but expendable in the presence of phosphorylation. Significantly, R117 is
located on a mobile helix, the α5 helix, that links the two domains, hence we speculate this residue
plays a significant role in communication between the two domains. Finally, we have developed a
preliminary SAXS model of RssB in complex with its substrate σS. Based on these data, we have
developed a preliminary model for the mechanism of action of RssB which we hope will stimulate
future efforts to study this novel adaptor protein. Clearly, further dissection of the delivery mechanism
is still required and additional biochemical and structural experiments are eagerly awaited.
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